aripiprazole + lamotrigine

**aripiprazole + lamotrigine** refers to the concomitant use of the two drugs: **aripiprazole**, an atypical antipsychotic, and **lamotrigine**, a mood stabilizer and anticonvulsant. - **Aripiprazole** acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors and an antagonist at serotonin 5-HT2A receptors, leading to modulation of dopaminergic and serotonergic neurotransmission. - **Lamotrigine** inhibits voltage-sensitive sodium channels, stabilizing neuronal membranes and suppressing the release of excitatory neurotransmitters like glutamate and aspartate. The combination is sometimes used in the management of **bipolar disorder**, particularly for the long-term prevention of mood episode relapses, and may be considered for major depressive disorder as augmentation in select cases. Clinical studies report efficacy in prolonging time to relapse in bipolar I disorder, though significance over monotherapy is variable[2][4][5]. Adverse effects reported include the potential for additive CNS depression, rare cases of intention tremor, and possibly an increased risk for neuroleptic malignant syndrome (NMS) when used with other antipsychotics or in vulnerable patients[1][2][3][6].